title: Caspase-cleaved TAR DNA-binding protein-43 in Pick's disease.
abstract: The hyperphosphorylation and proteolytic modification of the TAR DNA binding protein-43 (TDP-43) is a key finding in a number of neurodegenerative diseases including frontotemporal dementia with ubiquitin-positive inclusions (FTLD-U), amyotrophic lateral sclerosis (ALS), and most recently Alzheimer's disease (AD). To examine whether proteolytic modifications of TDP-43 is a relevant finding in Pick's disease, we utilized a novel site-directed caspase-cleavage antibody based upon a known caspase-3 cleavage consensus site within TDP-43 at position 219. Application of this antibody, termed TDP caspase-cleavage product (TDPccp) to postmortem Pick's disease brain sections revealed the presence of caspase-cleaved TDP-43 in Pick and Hirano bodies predominantly within region CA1 of the hippocampus. Co-localization of TDPccp with PHF-1, a general marker for Pick bodies, as well as with an antibody to caspase-cleaved tau (TauC3) was evident within the hippocampus. A semi-quantitative analysis indicated that approximately 21% and 79% of the Pick bodies identified in area CA1 contained caspase-cleaved TDP-43 or caspase-cleaved tau, respectively. Of interest was the lack of co-localization of TDPccp with PHF-1 in Pick bodies within the dentate gyrus. Collectively, these data have identified modified TDP-43 as a component of Pick and Hirano bodies that is restricted to area CA1 in Pick's disease. The relative paucity of caspase-cleaved TDP-43 found within Pick bodies in comparison to caspase-cleaved tau suggests that TDP-43 and its modification by caspases is most likely not a contributing factor leading to Pick body formation.
authors.affiliation: Department of Biology, Boise State University, Boise, Idaho, 83725.
authors.forename: Troy T
authors.initials: TT
authors.lastname: Rohn
authors.forename: Polina
authors.initials: P
authors.lastname: Kokoulina
references.citation: Mamm Genome. 2008 May;19(5):299-305
references.pmid: 18592312
references.citation: Neuropathology. 2006 Oct;26(5):484-90
references.pmid: 17080729
references.citation: Proc Natl Acad Sci U S A. 2003 Aug 19;100(17):10032-7
references.pmid: 12888622
references.citation: Biochem Biophys Res Commun. 2006 Dec 22;351(3):602-11
references.pmid: 17084815
references.citation: Neuropathol Appl Neurobiol. 1994 Feb;20(1):3-11
references.pmid: 8208338
references.citation: J Neurosci. 2007 Sep 26;27(39):10530-4
references.pmid: 17898224
references.citation: J Neuropathol Exp Neurol. 1987 Mar;46(2):185-99
references.pmid: 3029338
references.citation: Neurobiol Dis. 2002 Nov;11(2):341-54
references.pmid: 12505426
references.citation: Ann Neurol. 2007 May;61(5):435-45
references.pmid: 17469117
references.citation: Neuropathology. 2003 Dec;23(4):318-26
references.pmid: 14719549
references.citation: J Clin Invest. 2004 Jul;114(1):121-30
references.pmid: 15232619
references.citation: Acta Neuropathol. 2007 Jul;114(1):63-70
references.pmid: 17492294
references.citation: Brain Res. 2008 Sep 4;1228:189-98
references.pmid: 18634762
references.citation: Neurotherapeutics. 2008 Jul;5(3):443-57
references.pmid: 18625456
references.citation: Science. 2006 Oct 6;314(5796):130-3
references.pmid: 17023659
references.citation: J Neuropathol Exp Neurol. 2008 Jan;67(1):62-7
references.pmid: 18091558
references.citation: Brain Res. 1987 Feb 17;403(2):337-40
references.pmid: 3103867
references.citation: J Neurochem. 2008 May;105(3):797-806
references.pmid: 18088371
references.citation: Neurosignals. 2008;16(1):41-51
references.pmid: 18097159
references.citation: Neuropathol Appl Neurobiol. 2008 Feb;34(1):62-75
references.pmid: 17971079